Edison Open House - Global Healthcare 2021 - Interview with James Garner

@Richandpoor posted this on the Media thread and I have just watched it.

Information about royalties with Genentech, commercialisation possible in 2023, or 2024

James as excited as I have ever seen him, seems to be full of confidence in the data

Would recommend everybody watch this video especially the last ten minutes or so.

courtesy of @Rich&Poor  below

Edison Open House: Global Healthcare 2021 and will discuss the pivotal GBM AGILE study and the key upcoming milestones for Kazia in 2021.
Dr James Garner mentions:-
1 Patient alive more than 2 years after diagnosis with the phase 2 GBM trial.

The paxalisib recruitment arm commenced several weeks ago for the GBM AGILE study.

Potentially best in class toxicity for PI3K pathway.

During 2021 Kazia will focus on commercialization.

https://www.lsegissuerservices.com/spark/Kazia/events/4b08bd3c-338a-4a2e-b5c6-d5b0a94b5ea9

Regards